Skip to content

G protein‐coupled receptor modulation of striatal dopamine transmission: Implications for psychoactive drug effects

Mydirah Littlepage‐Saunders, Michael J. Hochstein, Doris S. Chang, Kari A. Johnson

British Journal of Pharmacology June 1, 2023 DOI: 10.1111/bph.16151 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Citations 5
Key findings The authors propose that GPCRs regulating striatal dopamine transmission act through two distinct routes: modulation of somatic action potential firing of dopamine neurons, and regulation of local acetylcholine-dependent dopamine release from striatal cholinergic interneurons. They argue these two modes likely affect different aspects of behaviour and psychoactive drug actions, and highlight the relevance of these mechanisms to drug effects on physiology and behaviour.

Abstract

Dopamine transmission in the striatum is a critical mediator of the rewarding and reinforcing effects of commonly misused psychoactive drugs. G protein-coupled receptors (GPCRs) that bind a variety of neuromodulators including dopamine, endocannabinoids, acetylcholine and endogenous opioid peptides regulate dopamine release by acting on several components of dopaminergic circuitry. Striatal dopamine release can be driven by both somatic action potential firing and local mechanisms that depend on acetylcholine released from striatal cholinergic interneurons. GPCRs that primarily regulate somatic firing of dopamine neurons via direct effects or modulation of synaptic inputs are likely to affect distinct aspects of behaviour and psychoactive drug actions compared with those GPCRs that primarily regulate local acetylcholine-dependent dopamine release in striatal regions. This review will highlight mechanisms by which GPCRs modulate dopaminergic transmission and the relevance of these findings to psychoactive drug effects on physiology and behaviour.

Citations in the library

Explore topics